Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Twitter

<< Previous

Bullboard Posts

Next >>

Comment by jordanlundon Mar 07, 2021 10:40am

154 Views

Post# 32738418

RE:RE:Twitter

Pareto8020 wrote: Wow completely surprised they came out and mentioned what the product does but looks like SBM's TFC-1067 is finally hitting shelves!!! Next week should be a wild run for SBM.

https://twitter.com/RodanFieldsHQ/status/1368562105637539841?s=20

wowowow. What a nice early surprise! I know rodan won't pump Sirona directly, but I hope Sirona's new PR team goes on an all out blitz, making it clear how significant this is and only the beginning.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in